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EDITORIAL – THORACIC ONCOLOGY

The Importance of Clinical Decision-Making in Surgical Planning
for Non-Small Cell Lung Cancer
Hollis Johanson, MD, and Ikenna Okereke, MD
Department of Surgery, Henry Ford Health System, Detroit, MI

Lung cancer is the leading cancer killer in the United
States and the world. Surgical resection remains an
important part of the treatment for non-small cell lung
cancer (NSCLC). Achieving negative surgical margins is a
critical factor in prognosis, and patients who have positive
margins experience worse survival.
The study by van Joolingen and colleagues1 analyzed
the ability of a nomogram they created to predict an R1 or
R2 resection in locally advanced NSCLC. This nomogram,
called the Rasing score, uses characteristics of the tumor
and planned surgical approach to assign a score. Tumor
histology, clinical T stage, clinical N stage, extent of
planned surgical resection (lobectomy, sub-lobar or wedge
resection, pneumonectomy, sleeve resection), and thoracoscopic versus open surgery are used as determinants of
the Rasing score.2
Patients are further divided into low-risk (Rasing score
0–2), medium-risk (Rasing score 2–4), and high-risk
(Rasing score C 4) cohorts for R1/R2 resection. In the
authors’ previous study, the probabilities of these groups
having a R1/R2 resection were respectively 3.3%, 8.4%,
and 19.8%. The current study used this prediction model to
analyze whether definitive chemoradiation for these
patients would resulted in improved overall survival for the
high-risk group with a Rasing score higher than 4.
As demonstrated in the authors’ report, the majority of
the patients (78.2%) with a Rasing score lower than 4
experienced an R0 resection. In the analysis of the patients
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in the high-risk group (Rasing score [ 4), those with an R0
resection had a median survival of 45.6 months and
experienced better survival than the patients who underwent definitive chemoradiation treatment. The patients
with positive resection margins had a poorer median survival than their matched chemoradiation cohort.
This article demonstrates the limitation of relying on a
nomogram alone to predict the ability to achieve a complete resection. When the resectability of a tumor is
evaluated, multiple factors are used. The National Comprehensive Cancer Network (NCCN) publishes guidelines
for addressing cancer treatment developed by agreement of
leaders in the field of surgical and medical oncology.3
Clinical stage, lymph node status, patient functionality, and
staging workup all are characteristics that determine suitability for surgery.
The Rasing score accounts for the planned surgical
resection, but it fails to capture the nuances routinely used
in the selection of patients for surgery. In addition, imaging
characteristics such as relationship to the great vessels and
other intrathoracic structures are not captured in the Rasing
score nomogram.
Not only tumor characteristics are important in predicting an R0 resection, but patient functional status also
needs to be addressed in the selection of the best treatment
approach. Pulmonary function tests, patient frailty, and
exercise tolerance all are important points to consider in
determining eligibility for surgery. These points are especially vital for patients who may require an extended
resection, such as a bi-lobectomy, to achieve negative
margins. For patients who do not seem able to tolerate the
necessary lung resection, neoadjuvant or definitive
chemoradiation may be a better option.
Additionally, the patient’s support system is an important factor to consider during the preoperative planning
phase. For patients who have limited social support,
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unsheltered housing, or continued tobacco/substance use,
addressing these issues before surgery will give them a
better chance to tolerate surgical resection. For these reasons, the treatment approach should be discussed in a
multidisciplinary setting with consideration of patient
factors and tumor characteristics.
In the management of lung cancer patients, the best
treatment approach is based on multiple factors. Tumor
location, size, presence of nodal metastases, and predicted
extent of resection guide the surgeon to choose the best
suitability for surgery. Furthermore, patient frailty and the
patient’s support system also will guide the treatment plan.
The authors should be applauded for their attempt to
create a predictive model to guide decision-making. But
this model should be used with other factors to determine
the best treatment plan for the patient.
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